Ignite Creation Date:
2024-05-06 @ 7:04 PM
Last Modification Date:
2024-10-26 @ 3:00 PM
Study NCT ID:
NCT05887895
Status:
COMPLETED
Last Update Posted:
2023-07-20
First Post:
2023-05-08
Brief Title:
To Compare the Pharmacokinetics and Pharmacodynamics of HR20014 INS068 and INS062 After Single Subcutaneous Injection in Healthy Subjects
Sponsor:
Jiangsu HengRui Medicine Co Ltd
Organization:
Jiangsu HengRui Medicine Co Ltd
Study Overview
Official Title:
A Trial Comparing the Pharmacodynamics and Pharmacokinetics of HR20014 INS068 and INS062 in Healthy Subjects
Status:
COMPLETED
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a single-center randomized open six-sequence three-period crossover phase I clinical trial in healthy subjects to compare the PKPD and safety profiles of single dose of HR20014 INS068 and INS062 In this study 12 subjects were randomly assigned to 6 administration sequences in a ratio of 111111 and HR20014 INS068 or INS062 injection were given subcutaneously three times before and after each sequence
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None